|
End-of-day quote
Other stock markets
|
||
| - GBX | - |
|
| 07-30 | Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US | RE |
| 07-30 | GSK global supply chain director sells 38,000 shares | AN |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 1,030B | A | ||||||||
| 617B | BBB | ||||||||
| 455B | AA | - | |||||||
| 350B | AA | ||||||||
| 299B | AAA | ||||||||
| 265B | A | ||||||||
| 225B | A | ||||||||
| 209B | A | ||||||||
| 163B | AA | ||||||||
| 142B | A | ||||||||
| 132B | A | ||||||||
| 122B | AA | ||||||||
| 101B | AA | ||||||||
| 72.96B | AA | ||||||||
| 57.26B | AA | ||||||||
| 54.79B | AA | ||||||||
| 53.29B | AA | ||||||||
| 43.65B | AA | ||||||||
| 41.26B | - | ||||||||
| Average | 233.33B | AA | |||||||
| Weighted average by Cap. | AA |
- Stock Market
- Stocks
- GSK Stock
- Stock
- Sector GlaxoSmithKline plc
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
















